The identified myeloma proteotype further suggested promising and recently investigated myeloma drug targets, including CDK5 (ref. 58) (Extended Data Fig. 5b) and endoplasmic reticulum (ER)-stress associated HSPA5 and HSP90B1 (ref. 59) (Supplementary Table 4). This evidence concerns the gene CDK5 and plasma cell myeloma.